Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Creo Medical (1RC) Stock Price & Analysis

2 Followers

1RC Stock Chart & Stats

€0.13-€0.00(-1.57%)
At close: 5:30 PM GMT+1
€0.14€0.16€0.18Sep 17Feb 18
Day’s Range
EUR 0.13 - EUR 0.13
52-Week Range
EUR 0.11 - EUR 0.21
Previous Close
EUR 0.13
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 58.59M
Enterprise Value
EUR 57.72M
Total Cash (Recent Filing)
EUR 12.40M
Total Debt (Recent Filing)
EUR 4.10M
Price to Earnings (P/E)
―
Beta
1.07
Next Earnings
Jun 02, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Manageable Leverage

Relatively low debt compared with equity gives Creo financial flexibility while it scales its medical-device business. This can help preserve capacity for commercial investment and product development, although the benefit depends on containing ongoing losses and cash use.

Installed-base Consumables Model

Creo’s platform-and-consumables model can create recurring revenue as hospitals and endoscopy providers use installed systems for procedures. Greater utilization could make revenue more repeatable over time and improve the economic value of each capital-equipment placement.

2025 Revenue Improvement

The 2025 revenue improvement indicates that commercial activity may be gaining traction after a period of weak growth. If sustained, higher sales would provide a broader base over which to absorb the cost structure and could support eventual operating leverage.

Bears Say

Persistent Operating Losses

Large recurring operating losses show that the current revenue base remains well below the scale needed to support Creo’s cost structure. Until core operations approach breakeven, growth may not translate into durable earnings and financial risk will remain elevated.

Sustained Cash Burn

Consistently negative operating and free cash flow means the business is not yet self-funding through normal operations. Continued cash outflows can constrain investment choices and increase reliance on existing cash or future financing if profitability does not improve.

Volatile Revenue And Earnings Quality

Revenue volatility makes future scale harder to forecast, while the 2025 bottom-line profit did not reflect a clear improvement in core operations. This weakens confidence that reported earnings are yet a durable measure of the underlying business trajectory.

Creo Medical News

1RC FAQ

What was Creo Medical’s price range in the past 12 months?
Creo Medical lowest stock price was €0.11 and its highest was €0.21 in the past 12 months.
What is Creo Medical’s market cap?
Creo Medical’s market cap is €58.59M.
When is Creo Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Creo Medical’s earnings last quarter?
Creo Medical released its earnings results on Sep 30, 2026. The company reported -€0.023 earnings per share for the quarter.
Is Creo Medical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Creo Medical pay dividends?
Creo Medical does not currently pay dividends.
What is Creo Medical’s EPS estimate?
Creo Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Creo Medical have?
Creo Medical has 449,139,980 shares outstanding.
What happened to Creo Medical’s price movement after its last earnings report?
Creo Medical reported an EPS of -€0.023 in its last earnings report. Following the earnings report the stock price went down -15.672%.
Which hedge fund is a major shareholder of Creo Medical?
Currently, no hedge funds are holding shares in DE:1RC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology